Left ventricular diastolic dysfunction and diastolic heart failure.

Thirty to fifty percent of patients presenting with signs and symptoms of heart failure have a normal left ventricular (LV) systolic ejection fraction. The clinical examination cannot distinguish these patients (diastolic heart failure) from those with a depressed ejection fraction (systolic heart failure), but echocardiography can. The management of diastolic heart failure has two major objectives. The first is to reverse the consequences of diastolic dysfunction (e.g., venous congestion), and the second is to eliminate or reduce the factors responsible for diastolic dysfunction (e.g., myocardial hypertrophy, fibrosis, and ischemia).

[1]  D. Brutsaert,et al.  New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. , 2002, Circulation.

[2]  S. Yusuf,et al.  Acute precipitants of congestive heart failure exacerbations. , 2001, Archives of internal medicine.

[3]  J. Carroll,et al.  Heart Failure With a Normal Ejection Fraction: Is Measurement of Diastolic Function Necessary to Make the Diagnosis of Diastolic Heart Failure? , 2001, Circulation.

[4]  G. Aurigemma,et al.  Reduced left ventricular systolic pump performance and depressed myocardial contractile function in patients > 65 years of age with normal ejection fraction and a high relative wall thickness. , 1995, The American journal of cardiology.

[5]  Thierry C. Gillebert,et al.  How to diagnose diastolic heart failure , 1998 .

[6]  Jean Charles Gilbert,et al.  Determinants of left ventricular filling and of the diastolic pressure-volume relation. , 1989, Circulation research.

[7]  I. Mirsky,et al.  Assessment of passive elastic stiffness of cardiac muscle: mathematical concepts, physiologic and clinical considerations, directions of future research. , 1976, Progress in cardiovascular diseases.

[8]  Michael V. Green,et al.  Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. , 1985, Circulation.

[9]  Mario J. Garcia,et al.  An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure. , 1997, Journal of the American College of Cardiology.

[10]  S. Keenan,et al.  The effect of positive pressure airway support on mortality and the need for intubation in cardiogenic pulmonary edema: a systematic review. , 1998, Chest.

[11]  G. Naccarelli,et al.  Congestive heart failure with normal systolic function. , 1984, The American journal of cardiology.

[12]  N. Alpert,et al.  Altered Myocardial Force‐Frequency Relation in Human Heart Failure , 1992, Circulation.

[13]  M. Quiñones,et al.  Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. , 1997, Journal of the American College of Cardiology.

[14]  D. Kitzman,et al.  Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization. , 2000, American heart journal.

[15]  R. Myerburg,et al.  Congestive heart failure: echocardiographic insights. , 1983, The American journal of medicine.

[16]  W. Gaasch,et al.  Left Ventricular Diastolic Dysfunction and Heart Failure , 1994 .

[17]  H. Sostman,et al.  Intact systolic left ventricular function in clinical congestive heart failure. , 1985, The American journal of cardiology.

[18]  P. Stone,et al.  Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function. , 1985, Archives of internal medicine.

[19]  R. Falk,et al.  Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis. , 1993, Chest.

[20]  S. Whiteley Comparison of nitroglycerin, morphine and furosemide in treatment of presumed prehospital pulmonary edema: Hoffman JR, Reynolds S Chest 92:586–593 Oct 1987 , 1988 .

[21]  D. Miller,et al.  Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension. , 1989, The American journal of cardiology.

[22]  A J Tajik,et al.  Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. , 1997, Journal of the American College of Cardiology.

[23]  W. Grossman,et al.  Impaired left ventricular relaxation during pacing-induced ischemia. , 1973, The American journal of cardiology.

[24]  D. Baim,et al.  Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. , 1984, Circulation.

[25]  M. Packer,et al.  Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. , 1990, Circulation.

[26]  D. Brutsaert,et al.  Dual control of relaxation. Its role in the ventricular function in the mammalian heart. , 1980, Circulation research.

[27]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[28]  K. Kessler Heart failure with normal systolic function. Update of prevalence, differential diagnosis, prognosis, and therapy. , 1988, Archives of internal medicine.

[29]  B. Massie,et al.  Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. , 1984, The American journal of cardiology.

[30]  K. Kessler Diastolic heart failure. Diagnosis and management. , 1989, Hospital practice.

[31]  D. Kitzman,et al.  Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. , 1991, Journal of the American College of Cardiology.

[32]  R. Bonow,et al.  Left ventricular diastolic function and calcium channel blockers in hypertrophic cardiomyopathy , 1994 .

[33]  B. Lorell,et al.  Effects of Ouabain and Isoproterenol on Left Ventricular Diastolic Function During Low‐Flow Ischemia in Isolated, Blood‐Perfused Rabbit Hearts , 1988, Circulation research.

[34]  W. Gaasch,et al.  Left Ventricular Stress and Compliance in Man: With Special Reference to Normalized Ventricular Function Curves , 1972, Circulation.

[35]  Jeffrey C. Hill,et al.  Usefulness of clinical variables, echocardiography, and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure. , 2003, The American journal of cardiology.

[36]  H. Black,et al.  Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. , 1990, The American journal of cardiology.

[37]  M. Quiñones,et al.  Estimation of left ventricular end-diastolic pressure from Doppler transmitral flow velocity in cardiac patients independent of systolic performance. , 1992, Journal of the American College of Cardiology.

[38]  W. Grossman Diastolic dysfunction and congestive heart failure. , 1990, Circulation.

[39]  Randolph P. Martin,et al.  Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. , 1996, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[40]  W. Gaasch,et al.  Left ventricular compliance: mechanisms and clinical implications. , 1976, The American journal of cardiology.

[41]  L. Stevenson,et al.  Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. , 1990, Circulation.

[42]  J. Ross,et al.  Nature and significance of alterations in myocardial compliance. , 1973, The American journal of cardiology.

[43]  W. J. Meek THE QUESTION OF CARDIAC TONUS , 1927 .

[44]  D. Brutsaert,et al.  New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. , 2002, Circulation.

[45]  S. Glantz,et al.  Factors which affect the diastolic pressure-volume curve. , 1978, Circulation research.

[46]  D. Kitzman,et al.  The pathogenesis of acute pulmonary edema associated with hypertension. , 2001, The New England journal of medicine.

[47]  J. Ross Editorial: Acute Displacement of the Diastolic Pressure-Volume Curve of the Left Ventricle Role of the Pericardium and the Right Ventricle , 1979, Circulation.

[48]  W Grossman,et al.  Diastolic properties of the left ventricle. , 1976, Annals of internal medicine.

[49]  K. Bailey,et al.  Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. , 1998, Circulation.

[50]  W. Colucci,et al.  Nesiritide for the treatment of decompensated heart failure. , 2001, Journal of cardiac failure.

[51]  A. DeMaria,et al.  Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: Comparison With Doppler Velocity Recordings , 2002, Circulation.

[52]  E. Topol,et al.  Hypertensive hypertrophic cardiomyopathy of the elderly. , 1985, The New England journal of medicine.

[53]  D. Levy,et al.  Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. , 1999, Journal of the American College of Cardiology.

[54]  J. Weiss,et al.  The effects of antihypertensive therapy on left ventricular mass in elderly patients. , 1990, The New England journal of medicine.

[55]  J. Hoffman,et al.  Comparison of nitroglycerin, morphine and furosemide in treatment of presumed pre-hospital pulmonary edema. , 1987, Chest.

[56]  W. White,et al.  Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. , 1986, Journal of the American College of Cardiology.

[57]  L. Lenert,et al.  Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. , 2001, Journal of the American College of Cardiology.

[58]  R. Bonow,et al.  Hypertrophic cardiomyopathy. , 1987, Disease-a-month : DM.

[59]  J. Gardin,et al.  Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. , 2001, Journal of the American College of Cardiology.

[60]  W. Gaasch,et al.  Recognition and treatment of left ventricular diastolic dysfunction. , 1990, Progress in cardiovascular diseases.

[61]  W. Gaasch Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction. , 1994, JAMA.

[62]  M. Frenneaux,et al.  Mechanisms of exercise limitation in hypertrophic cardiomyopathy. , 1992, Journal of the American College of Cardiology.

[63]  D. Kitzman,et al.  Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. , 1999, Journal of the American College of Cardiology.

[64]  J. Thomas,et al.  A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. , 1996, Journal of the American College of Cardiology.

[65]  W. Hundley,et al.  Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. , 2002, JAMA.

[66]  P. Poole‐Wilson,et al.  Pathogenesis of Congestive State in Chronic Obstructive Pulmonary Disease: Studies of Body Water and Sodium, Renal Function, Hemodynamics, and Plasma Hormones During Edema and After Recovery , 1992, Circulation.

[67]  J. Firth,et al.  RAISED VENOUS PRESSURE: A DIRECT CAUSE OF RENAL SODIUM RETENTION IN OEDEMA? , 1988, The Lancet.

[68]  S. Ommen,et al.  Clinical Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Left Ventricular Filling Pressures: A Comparative Simultaneous Doppler-Catheterization Study , 2000, Circulation.

[69]  K. Schulman Book ReviewThe Medical Cost-Containment Crisis: Fears, opinions, and facts , 1990 .

[70]  J. Carroll,et al.  Role of adrenoceptors and dopamine receptors in modulating left ventricular diastolic function. , 1988, Circulation research.

[71]  R. Bonow,et al.  Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Diastolic mechanisms for systolic dysfunction during exercise. , 1990, Circulation.

[72]  S. Verma,et al.  Glitazones and heart failure: critical appraisal for the clinician. , 2003, Circulation.

[73]  Miller Ne,et al.  Letter: High-density lipoprotein and atherosclerosis. , 1975, Lancet.

[74]  K. Weber,et al.  Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.

[75]  K. Caidahl,et al.  Dyspnoea of cardiac origin in 67 year old men: (2). Relation to diastolic left ventricular function and mass. The study of men born in 1913. , 1988, British heart journal.

[76]  B. Massie,et al.  Heart failure in patients with preserved left ventricular systolic function: do digitalis glycosides have a role? , 1998, Progress in cardiovascular diseases.

[77]  E. Dwyer Left Ventricular Pressure‐Volume Alterations and Regional Disorders of Contraction During Myocardial Ischemia Induced by Atrial Pacing , 1970, Circulation.

[78]  M. Senni,et al.  Heart failure with preserved systolic function. A different natural history? , 2001, Journal of the American College of Cardiology.

[79]  M. Sherrid,et al.  Coronary revascularization for recurrent pulmonary edema in elderly patients with ischemic heart disease and preserved ventricular function. , 1985, The New England journal of medicine.

[80]  W. Williams,et al.  Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.

[81]  Carl J. Wiggers,et al.  THE CONTOUR OF THE VENTRICULAR VOLUME CURVES UNDER DIFFERENT CONDITIONS , 1922 .

[82]  D. Kass,et al.  Diminished Contractile Response to Increased Heart Rate in Intact Human Left Ventricular Hypertrophy Systolic Versus Diastolic Determinants , 1993, Circulation.

[83]  B. Maron,et al.  Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status. , 1979, Circulation.

[84]  R. Vasan,et al.  Defining diastolic heart failure: a call for standardized diagnostic criteria. , 2000, Circulation.

[85]  A. DeMaria,et al.  Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction , 2002 .

[86]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.